• The lancet oncology · Jun 2024

    Review

    Production and regulatory issues for theranostics.

    • Francesco Giammarile, Diana Paez, Richard Zimmermann, Cathy S Cutler, Amirreza Jalilian, Aruna Korde, Peter Knoll, Nayyereh Ayati, Jason S Lewis, Suzanne E Lapi, Roberto C Delgado Bolton, Jolanta Kunikowska, Estrada LobatoEnriqueEDivision of Human Health, Department of Nuclear Safety and Security, International Atomic Energy Agency, Vienna, Austria., Jean-Luc Urbain, Ola Holmberg, May Abdel-Wahab, and Andrew M Scott.
    • Division of Human Health, Department of Nuclear Safety and Security, International Atomic Energy Agency, Vienna, Austria.
    • Lancet Oncol. 2024 Jun 1; 25 (6): e260e269e260-e269.

    AbstractTheranostics has become a major area of innovation and progress in cancer care over the last decade. In view of the introduction of approved therapeutics in neuroendocrine tumours and prostate cancer in the last 10 years, the ability to provide access to these treatments has emerged as a key factor in ensuring global benefits from this cancer therapy approach. In this Series paper we explore the issues that affect access to and availability of theranostic radiopharmaceuticals, including supply and regulatory issues that might affect the availability of theranostic treatments for patients with cancer.Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…